Cubist Pharmaceuticals Inc

Strategic Corporate Assessment Strategy, SWOT Analysis and 5-year Financial Insights with In-depth Company Profile

Publication Date	August 2008
Publisher	Datamonitor
Product Type	Report
Pages	53
ISBN Number	not applicable
Product Code	DAT08644

Price

£265.00
approximately: $394 | €312

PDF

PRINT £315 ($468 | €371)

Order above formats by FAX

Summary

Introduction

Cubist Pharmaceuticals is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. Cubicin, Cubist's major product, is approved for multiple indications in many countries. In the US, Cubicin is being marketed for the treatment of complicated skin structure infections (cSSI).

Scope

Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Cubist has one marketed product, Cubicin, an antibiotic from a class of antiinfectives called lipopeptides, for the treatment of complicated skin and skin structure infections, and for other blood-stream infections. The company's research and development programs include lipopeptide programs.Cubist has research collaboration with Ilypsa to develop ILY103, a non-antibiotic, toxin binder therapy for the treatment of clostridium difficile associated diarrhea which is in preclinical trials.
Cubist derives its revenues from the product sales of Cubicin and other revenues which includes license agreements revenues, Small Business Innovation Research (SBIR) and grant revenue. Cubist's total revenues increased at a CAGR of 103% during 2002-2006, from $11 million in 2002 to $195 million in 2006.

Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content

Overview
Catalyst
Summary
Company Structure
Company Overview and Key Facts
Business Description
History
Company Financials
Stock Market Performance
P&L
Balance Sheet
Cash Flow
Products & Services
Marketed Products
Pipeline Products
Historical Product Sales
AC Forecast Product Sales
Competitors and Strategic Business Relationships
Key Competitors
Key Suppliers
Key Clients
Shareholding Structure
Strategy
Company View
Corporate Strategy
SWOT Analysis
Overview
Strengths
Weaknesses
Opportunities
Threats
Value Chain Analysis
Overview
Discovery and Product Development
Manufacturing
Sales
Scorecard
Overview
Scorecard Analysis
Key Employees
List of Key Employees
Key Employee Biographies
Financial and Operational Overview
Financial and Operational Overview
APPENDIX
Ask the analyst
Datamonitor consulting
Disclaimer
TABLE OF FIGURES
- Figure1: Cubist Pharmaceuticals Key Strategic Revenues, 200307 ($ Mn)
- Figure2: Cubist Pharmaceuticals Operating Revenue/Cost Analysis, 200307 ($ Mn)
- Figure3: Cubist Pharmaceuticals Key Strategic Revenues, 200711 ($ Mn)
TABLE OF TABLES
- Table 1: Cubist Pharmaceuticals Key Facts
- Table 2: Cubist Pharmaceuticals Year-End Share Price and Market Capitalization, 200307
- Table 3: Cubist Pharmaceuticals Key Events Impacting Share Price Performance, 200307
- Table 4: Cubist Pharmaceuticals Operating Revenue/Cost Analysis, 200307 ($ Mn)
- Table 5: Cubist Pharmaceuticals Operating Cost Ratio Analysis, 200307 (% of total revenues)
- Table 6: Cubist Pharmaceuticals Balance Sheet, 200307 ($ Mn)
- Table 7: Cubist Pharmaceuticals Cash Flow, 200307 ($ Mn)
- Table 8: Cubist Pharmaceuticals Marketed Products
- Table 9: Cubist Pharmaceuticals In-house Pipeline Products
- Table 10: Cubist Pharmaceuticals Historical Product Sales, 200307 ($ Mn)
- Table 11: Cubist Pharmaceuticals Forecast Sales, 200711 ($ Mn)
- Table 12: Cubist Pharmaceuticals Key Competitors
- Table 13: Cubist Pharmaceuticals Key Suppliers
- Table 14: Cubist Pharmaceuticals Key Clients
- Table 15: Cubist Pharmaceuticals Key Shareholders
- Table 16: Cubist Pharmaceuticals SWOT Analysis Summary
- Table 17: Cubist Pharmaceuticals Value Chain Analysis
- Table 18: Cubist Pharmaceuticals Scorecard
- Table 19: Cubist Pharmaceuticals Key Employees
- Table 20: Cubist Pharmaceuticals Financial and Operational Overview, 200307